Medezrin takes 0.7% stake in Newalr&D, biotech research firm
Published
Medezrin Ltd entered Newalr&D Ltd’s register with 200 ordinary shares, giving it a 0.7% stake. It is the only new corporate holder identified in the filing. Northlea Partners LLLP and Alchemy Ventures Group LLC also increased their ordinary holdings, indicating wider movement among existing fund shareholders. The confirmation statement was filed on 17 October 2025 and covers the period to 14 October 2025.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| New shareholder | MEDEZRIN LTD | 200 | — | ORDINARY 200 |
Current shareholders (3)
| Shareholder | Total shares | Share classes |
|---|---|---|
| ALCHEMY VENTURES GROUP LLC | 2,111 | ORDINARY 2,111 |
| NORTHLEA PARTNERS LLLP | 2,077 | ORDINARY 2,077 |
| MEDEZRIN LTD | 200 | ORDINARY 200 |
Contact the editorial team at editorial@fundingspotter.com